Kathleen Gondek, PhD, is currently the Global Head of Outcomes Research and Epidemiology at Takeda.
Kathleen spent the last four years at Shire as Global Head of Outcomes Research and Epidemiology. Prior to joining Shire she was Vice President, US Medical Science Liaisons and Medical Affairs Operations at Bayer HealthCare pharmaceuticals. Prior to this role Kathleen held a number of positions, of increasing responsibility, within the Health Economics and Outcomes Research (HEOR) function at Bayer that span a 15-year career with the organization. These include Director HEOR US, Head of Global HEOR for Life Cycle Management, Anti-infectives, Men’s Health and Oncology and Vice President, Global Health Economics and Outcomes Research, Specialty Medicine. Prior to joining Bayer, Kathleen worked at Boehringer Ingelheim Pharmaceuticals. Kathleen is a coauthor on 45 peer reviewed publications and over 100 presentations.
Kathleen holds a Bachelor’s Degree in Pharmacy from the State University of New York at Buffalo and a PhD in Pharmacy Practice and Administrative Science from the University of Maryland at Baltimore. While at Bayer, Kathleen was a lecturer at Yale University in the School of Public Health.